Today: 9 June 2026
Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week
7 February 2026
2 mins read

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

New York, Feb 7, 2026, 02:50 EST — Market closed

  • Rio Tinto’s U.S. shares jumped roughly 2.5% on Friday, after the miner said no to a deal with Glencore.
  • The miner’s announcement sets off a six-month “no-bid” lockout, as required by UK takeover rules.
  • Attention turns to Rio’s Feb. 19 annual results, with iron ore prices also in focus as China moves into its holiday lull.

Rio Tinto’s U.S. shares ended Friday up roughly 2.5% at $93.37, after the company confirmed it won’t move forward with a Glencore merger. That decision put to rest weeks of speculation swirling over the sector.

This decision is significant; traders had begun factoring in the possibility of a major industry shift—and the chance Rio would shell out big to make it happen. With Rio stepping back, one overhang disappears. Still, the lingering issue for investors remains: can returns improve without a headline-grabbing transaction.

On Feb. 5, Rio dropped plans for a merger or any other kind of business tie-up with Glencore, saying talks failed to yield a deal it thought would benefit its shareholders. The company said it reviewed the proposal using the “disciplined lens” outlined at its capital markets day back in December. https://www.riotinto.com/en/news/releases/…

The comment falls under Rule 2.8 of the UK Takeover Code—a formal “no intention to bid” announcement, meaning no new offer can come for six months unless certain exceptions apply. That six-month window quiets takeover talk for now, though it doesn’t kill the speculation. https://www.riotinto.com/en/news/releases/…

Glencore’s board pushed back, saying negotiations broke down over terms. The company argued that the deal would have left Glencore—especially its copper assets and development projects—undervalued. “We concluded that the proposed acquisition on these terms is not in the best interests of Glencore shareholders,” Glencore said. https://www.glencore.com/media-and-insight…

Valuation issues kept resurfacing, both investors and analysts say. “The strategic logic was always apparent, but perhaps finding a shared view on valuation was always going to be challenging,” Aberdeen’s Iain Pyle told Reuters. https://www.reuters.com/world/asia-pacific…

Rio’s stock faces pressure from commodity moves—iron ore in particular, which remains the backbone of its profits. Iron ore futures fell under $100 a tonne on Friday, Bloomberg News reported, with traders pointing to sluggish Chinese demand leading up to Lunar New Year and a well-supplied market.

The risk is clear enough. Should iron ore prices slip more, or if China’s appetite for steel doesn’t hold up, Rio’s recent rebound could unravel fast. That would likely put the spotlight back on whether the company needs to lean harder into copper—regardless of fresh M&A chatter.

Looking ahead, Rio’s 2025 annual results land Feb. 19, and that’s the date traders have circled. Dividend plans, cost outlook, and fresh details on capital spending—especially following the failed merger talks—are all likely to get close attention.

Stock Market Today

  • San ju San Financial Group (TSE:7322) Valuation Review Amid Share Gains
    June 9, 2026, 9:48 AM EDT. San ju San Financial Group Inc (TSE:7322), a regional Japanese bank, has seen strong share price gains over recent periods. The stock trades at a price-to-earnings (P/E) ratio of 14.2x, slightly above the Japan banks sector average of 13.8x but near peer levels of 14.6x. This reflects investor confidence following a 42.7% earnings increase and improved profit margins from 12.4% to 15%. However, discounted cash flow (DCF) models suggest the stock may be overvalued, with current prices exceeding estimated future cash flow values. Market valuation appears to price in San ju San's recent profitability, but any changes in earnings trajectory or credit risks could impact the outlook. The company holds a market capitalization of approximately ¥167.4 billion and remains under investor scrutiny amid a strong five-year shareholder return.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Xero share price slides 14% in a week — what to watch next for ASX:XRO
Previous Story

Xero share price slides 14% in a week — what to watch next for ASX:XRO

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive
Next Story

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Go toTop